FMC7 is a transmembrane glycoprotein with a molecular weight of 105 kDa. This antigen was described as a particular conformation of a surface protein encoded by the CD20 gene. FMC7 antibody reactivity to its particular CD20 epitope was found to be dependent of membrane cholesterol level. In circulating blood cells, FMC7 is expressed by a B lymphocyte sub-population. It is not detected on T lymphocytes, NK cells, polymorphonuclear granulocytes, platelets, nor on erythrocytes. The subpopulation of B lymphocytes expressing the FMC7 antgen expresses surface immunoglobulins, thus defining a stage of maturation of the B lymphocytes distinct from FMC7– B lymphocytes.

Specifications

Specificity FMC7
Form Pacific Blue*
Clone FMC7
Flow Product Line IOTest
Clone Description The FMC7 antibody reacts with a subpopulation of peripheral blood B lymphocytes and tonsil B cells, but it does not react with granulocytes, monocytes, platelets, erythrocytes, T lymphocytes or null cells.
Isotype IgG1 Mouse
Format Liquid
Size 50 Tests
Target Species Human
Regulatory Status CE

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS

The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.